scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...744668S |
P356 | DOI | 10.1371/JOURNAL.PONE.0044668 |
P932 | PMC publication ID | 3433444 |
P698 | PubMed publication ID | 22962622 |
P5875 | ResearchGate publication ID | 230827324 |
P50 | author | João E. Fonseca | Q43138417 |
Maria J. Santos | Q51064290 | ||
Diana Carmona-Fernandes | Q57026307 | ||
Victor Gil | Q57027529 | ||
P2093 | author name string | Helena Canhão | |
José Canas da Silva | |||
P2860 | cites work | Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors | Q40336362 |
Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB | Q40345995 | ||
Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study | Q40564036 | ||
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study | Q40873641 | ||
Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis | Q41992252 | ||
Vascular stiffness in women with systemic lupus erythematosus | Q43576508 | ||
The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women | Q43810753 | ||
Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity | Q44574975 | ||
Endothelial function predicts progression of carotid intima-media thickness | Q46127803 | ||
Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year followup study of 108 patients with rheumatoid arthritis | Q46454542 | ||
Circulating thrombomodulin and vascular cell adhesion molecule-1 and renal vascular lesion in patients with lupus nephritis | Q46484864 | ||
Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus | Q46724748 | ||
Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction | Q47273525 | ||
Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody | Q47368581 | ||
Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression. | Q51375410 | ||
Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus. | Q51672774 | ||
Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. | Q53600925 | ||
Arterial Stiffness and Risk of Coronary Heart Disease and Stroke | Q57781936 | ||
Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies | Q71150772 | ||
The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis | Q71605264 | ||
The distribution of adhesion molecules in human atherosclerosis | Q72090021 | ||
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse | Q74582629 | ||
Systemic lupus erythematosus disease activity index 2000 | Q77624632 | ||
Lack of association between carotid intima-media wall thickness and carotid plaques and markers of endothelial cell activation in rheumatoid arthritis patients undergoing anti-TNF therapy | Q85427188 | ||
A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways | Q24291492 | ||
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study | Q33387473 | ||
Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment | Q33531382 | ||
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis | Q33686973 | ||
Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study | Q33766242 | ||
The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients | Q33796222 | ||
Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils | Q33802771 | ||
Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness | Q34153114 | ||
Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden | Q34206247 | ||
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 | ||
Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. | Q34626669 | ||
Endothelial dysfunction: a marker of atherosclerotic risk | Q35067247 | ||
Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease | Q35557952 | ||
CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study | Q35617726 | ||
Noninvasive assessment of preclinical atherosclerosis | Q36012908 | ||
The lp13.3 genomic region -rs599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis. | Q36245657 | ||
Evolving functions of endothelial cells in inflammation | Q36950913 | ||
Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. | Q36952629 | ||
A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus | Q37369357 | ||
High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis | Q37775403 | ||
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. | Q37883018 | ||
Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation | Q37900782 | ||
Vascular function and morphology in rheumatoid arthritis: a systematic review | Q37934239 | ||
Endothelial function | Q37970041 | ||
Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease | Q39650370 | ||
Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events | Q39921103 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e44668 | |
P577 | publication date | 2012-09-04 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Early vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk | |
P478 | volume | 7 |
Q38123419 | 'Focus on feet'--the effects of systemic lupus erythematosus: a narrative review of the literature |
Q92051649 | A Study of the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis |
Q40644781 | An Investigation into the Scale and Impact of Self-Reported Foot Problems Associated with Systemic Lupus Erythematosus: A Study Protocol and Survey Questionnaire Development. |
Q37687986 | Aspirin for prevention of preeclampsia in lupus pregnancy |
Q33622254 | Calciphylaxis induced by warfarin therapy in a patient with anti-phospholipid antibody syndrome associated with systemic lupus erythematosus |
Q50072965 | Endothelial nitric oxide synthase modulates Toll-like receptor 4-mediated IL-6 production and permeability via nitric oxide-independent signaling |
Q57830832 | Immune-Mediated Inflammatory Rheumatic Diseases |
Q88945515 | Microvascular endothelial dysfunction in rheumatoid arthritis |
Q42474294 | Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding. |
Q51076609 | Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus. |
Q36054458 | Soluble ICAM-1, Independent of IL-6, Is Associated with Prevalent Frailty in Community-Dwelling Elderly Taiwanese People |
Q89314644 | Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases |
Q38069578 | The emerging role of neutrophils in thrombosis-the journey of TF through NETs |
Q38844782 | Update on cardiovascular disease in lupus |
Search more.